nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—GRK7—eye—refractive error	0.0191	0.138	CbGeAlD
Ruxolitinib—GRK7—retina—refractive error	0.0189	0.137	CbGeAlD
Ruxolitinib—GRK1—eye—refractive error	0.0138	0.0999	CbGeAlD
Ruxolitinib—GRK1—retina—refractive error	0.0137	0.099	CbGeAlD
Ruxolitinib—CAMK1D—eye—refractive error	0.00812	0.0587	CbGeAlD
Ruxolitinib—CAMK1D—retina—refractive error	0.00804	0.0582	CbGeAlD
Ruxolitinib—ROCK1—eye—refractive error	0.00716	0.0518	CbGeAlD
Ruxolitinib—ROCK1—retina—refractive error	0.0071	0.0513	CbGeAlD
Ruxolitinib—CAMK2G—eye—refractive error	0.00623	0.045	CbGeAlD
Ruxolitinib—MAP3K7—retina—refractive error	0.00555	0.0401	CbGeAlD
Ruxolitinib—TYK2—eye—refractive error	0.0055	0.0398	CbGeAlD
Ruxolitinib—TYK2—retina—refractive error	0.00545	0.0394	CbGeAlD
Ruxolitinib—MKNK2—eye—refractive error	0.00543	0.0393	CbGeAlD
Ruxolitinib—MKNK2—retina—refractive error	0.00538	0.0389	CbGeAlD
Ruxolitinib—TAOK3—eye—refractive error	0.0044	0.0318	CbGeAlD
Ruxolitinib—TAOK3—retina—refractive error	0.00436	0.0315	CbGeAlD
Ruxolitinib—JAK2—Developmental Biology—COL9A1—refractive error	0.000215	0.000249	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—OR2M7—refractive error	0.000211	0.000245	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—AXL—refractive error	0.000211	0.000244	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 interactions—PDGFRA—refractive error	0.000209	0.000242	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR in disease—PDGFRA—refractive error	0.000209	0.000242	CbGpPWpGaD
Ruxolitinib—JAK2—Fc epsilon receptor (FCERI) signaling—PDGFRA—refractive error	0.000209	0.000242	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—LUM—refractive error	0.000209	0.000242	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—WNT10A—refractive error	0.000208	0.000242	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—AXL—refractive error	0.000207	0.00024	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR—PDGFRA—refractive error	0.000207	0.00024	CbGpPWpGaD
Ruxolitinib—JAK1—Downstream signal transduction—PTEN—refractive error	0.000207	0.00024	CbGpPWpGaD
Ruxolitinib—JAK1—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.000206	0.000239	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by FGFR—PTEN—refractive error	0.000206	0.000239	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—GREM2—refractive error	0.000205	0.000238	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—BMP2—refractive error	0.000205	0.000238	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—OR2M7—refractive error	0.000205	0.000238	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR in Cancer—PDGFRA—refractive error	0.000205	0.000238	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by ERBB2—PTEN—refractive error	0.000205	0.000237	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by PDGF—PDGFRA—refractive error	0.000204	0.000237	CbGpPWpGaD
Ruxolitinib—JAK1—DAP12 signaling—PTEN—refractive error	0.000204	0.000236	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—IPO5—refractive error	0.000203	0.000236	CbGpPWpGaD
Ruxolitinib—ROCK1—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.000202	0.000235	CbGpPWpGaD
Ruxolitinib—MAP3K7—DNA Damage Response (only ATM dependent)—PTEN—refractive error	0.000202	0.000235	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—PDGFRA—refractive error	0.0002	0.000232	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—OR2M7—refractive error	0.000199	0.000231	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—RNF111—refractive error	0.000198	0.00023	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—RNF111—refractive error	0.000196	0.000227	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CER1—refractive error	0.000196	0.000227	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TJP2—refractive error	0.000196	0.000227	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—PML—refractive error	0.000195	0.000227	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—PDGFRA—refractive error	0.000193	0.000224	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—VANGL2—refractive error	0.000193	0.000224	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—RNF111—refractive error	0.000192	0.000223	CbGpPWpGaD
Ruxolitinib—JAK1—DAP12 interactions—PTEN—refractive error	0.000192	0.000222	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by FGFR in disease—PTEN—refractive error	0.000192	0.000222	CbGpPWpGaD
Ruxolitinib—JAK1—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.000192	0.000222	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by EGFR—PTEN—refractive error	0.00019	0.00022	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—VANGL2—refractive error	0.000189	0.00022	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—PAX6—refractive error	0.000189	0.000219	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—DSE—refractive error	0.000189	0.000219	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—WNT10A—refractive error	0.000189	0.000219	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by EGFR in Cancer—PTEN—refractive error	0.000188	0.000218	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—PDGFRA—refractive error	0.000188	0.000218	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by PDGF—PTEN—refractive error	0.000187	0.000217	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—RNF111—refractive error	0.000186	0.000216	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—BMP2—refractive error	0.000186	0.000215	CbGpPWpGaD
Ruxolitinib—JAK2—NGF signalling via TRKA from the plasma membrane—PDGFRA—refractive error	0.000185	0.000215	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—PDGFRA—refractive error	0.000183	0.000212	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by NGF—PTEN—refractive error	0.00018	0.000209	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—VIPR2—refractive error	0.00018	0.000209	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—WNT10A—refractive error	0.000179	0.000208	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—PML—refractive error	0.000179	0.000208	CbGpPWpGaD
Ruxolitinib—ROCK1—Focal Adhesion—PTEN—refractive error	0.000178	0.000207	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—RDH5—refractive error	0.000178	0.000206	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—RNF111—refractive error	0.000178	0.000206	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—WNT10A—refractive error	0.000176	0.000204	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—COL9A1—refractive error	0.000176	0.000204	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—PML—refractive error	0.000175	0.000203	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CHN1—refractive error	0.000174	0.000202	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—VIPR2—refractive error	0.000174	0.000202	CbGpPWpGaD
Ruxolitinib—JAK1—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.00017	0.000197	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—WNT10A—refractive error	0.00017	0.000197	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by SCF-KIT—PTEN—refractive error	0.00017	0.000197	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—VIPR2—refractive error	0.000169	0.000196	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—RDH5—refractive error	0.000169	0.000196	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—RPS27—refractive error	0.000169	0.000196	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CTSC—refractive error	0.000168	0.000195	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—RNF111—refractive error	0.000168	0.000195	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TJP2—refractive error	0.000168	0.000195	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CER1—refractive error	0.000168	0.000195	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PCCA—refractive error	0.000168	0.000195	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CER1—refractive error	0.000166	0.000192	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—RNF111—refractive error	0.000166	0.000192	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TJP2—refractive error	0.000166	0.000192	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—PDGFRA—refractive error	0.000165	0.000192	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—PML—refractive error	0.000165	0.000191	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—RDH5—refractive error	0.000164	0.00019	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CTSC—refractive error	0.000163	0.00019	CbGpPWpGaD
Ruxolitinib—TYK2—Downstream signaling of activated FGFR—PTEN—refractive error	0.000162	0.000188	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—AXL—refractive error	0.00016	0.000186	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by ERBB4—PTEN—refractive error	0.00016	0.000185	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—RDH5—refractive error	0.000159	0.000185	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CTSC—refractive error	0.000159	0.000184	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—OR2M7—refractive error	0.000156	0.00018	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—AXL—refractive error	0.000156	0.00018	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—IPO5—refractive error	0.000154	0.000179	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—LUM—refractive error	0.000154	0.000179	CbGpPWpGaD
Ruxolitinib—TYK2—Downstream signal transduction—PTEN—refractive error	0.000153	0.000177	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by FGFR—PTEN—refractive error	0.000152	0.000176	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by ERBB2—PTEN—refractive error	0.000151	0.000175	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—AXL—refractive error	0.000151	0.000175	CbGpPWpGaD
Ruxolitinib—TYK2—DAP12 signaling—PTEN—refractive error	0.00015	0.000174	CbGpPWpGaD
Ruxolitinib—MAP3K7—Insulin Signaling—PTEN—refractive error	0.000149	0.000173	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—COL9A1—refractive error	0.000148	0.000172	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—VANGL2—refractive error	0.000147	0.00017	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—RNF111—refractive error	0.000146	0.000169	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—PDGFRA—refractive error	0.000145	0.000168	CbGpPWpGaD
Ruxolitinib—MAP3K7—Downstream signaling events of B Cell Receptor (BCR)—PTEN—refractive error	0.000144	0.000167	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—PAX6—refractive error	0.000143	0.000166	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—WNT10A—refractive error	0.000143	0.000166	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—VANGL2—refractive error	0.000142	0.000165	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—PDGFRA—refractive error	0.000142	0.000165	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—PML—refractive error	0.000142	0.000165	CbGpPWpGaD
Ruxolitinib—JAK2—PDGFR-beta signaling pathway—PTEN—refractive error	0.000142	0.000164	CbGpPWpGaD
Ruxolitinib—TYK2—DAP12 interactions—PTEN—refractive error	0.000141	0.000164	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by FGFR in disease—PTEN—refractive error	0.000141	0.000164	CbGpPWpGaD
Ruxolitinib—TYK2—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.000141	0.000164	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by EGFR—PTEN—refractive error	0.00014	0.000163	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by EGFR in Cancer—PTEN—refractive error	0.000139	0.000161	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by PDGF—PTEN—refractive error	0.000138	0.00016	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—VANGL2—refractive error	0.000138	0.00016	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—CYP26A1—refractive error	0.000137	0.000159	CbGpPWpGaD
Ruxolitinib—MAP3K7—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.000137	0.000159	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—WNT10A—refractive error	0.000136	0.000158	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—PDGFRA—refractive error	0.000136	0.000158	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metapathway biotransformation—CYP26A1—refractive error	0.000135	0.000157	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—RNF111—refractive error	0.000135	0.000156	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—WNT10A—refractive error	0.000132	0.000153	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—VIPR2—refractive error	0.000132	0.000153	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by NGF—PTEN—refractive error	0.00013	0.000151	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by SCF-KIT—PTEN—refractive error	0.000129	0.000149	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—WNT10A—refractive error	0.000128	0.000149	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TJP2—refractive error	0.000128	0.000149	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—PDGFRA—refractive error	0.000128	0.000149	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CER1—refractive error	0.000128	0.000149	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—RNF111—refractive error	0.000128	0.000149	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—COL9A1—refractive error	0.000128	0.000148	CbGpPWpGaD
Ruxolitinib—MAP3K7—B Cell Activation—PTEN—refractive error	0.000127	0.000147	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—COL9A1—refractive error	0.000126	0.000146	CbGpPWpGaD
Ruxolitinib—TYK2—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.000125	0.000145	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—RPS27—refractive error	0.000124	0.000144	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—RNF111—refractive error	0.000124	0.000144	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RDH5—refractive error	0.000124	0.000144	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TJP2—refractive error	0.000124	0.000144	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CER1—refractive error	0.000124	0.000144	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CTSC—refractive error	0.000124	0.000144	CbGpPWpGaD
Ruxolitinib—JAK2—Downstream signaling of activated FGFR—PTEN—refractive error	0.000123	0.000143	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB4—PTEN—refractive error	0.000121	0.00014	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CER1—refractive error	0.000121	0.00014	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—RNF111—refractive error	0.000121	0.00014	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TJP2—refractive error	0.000121	0.00014	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—BMP2—refractive error	0.00012	0.00014	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AXL—refractive error	0.000118	0.000137	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—LUM—refractive error	0.000117	0.000135	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—PDGFRA—refractive error	0.000116	0.000135	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—PDGFRA—refractive error	0.000116	0.000134	CbGpPWpGaD
Ruxolitinib—JAK2—Downstream signal transduction—PTEN—refractive error	0.000116	0.000134	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR—PTEN—refractive error	0.000115	0.000133	CbGpPWpGaD
Ruxolitinib—JAK2—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.000115	0.000133	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB2—PTEN—refractive error	0.000114	0.000133	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 signaling—PTEN—refractive error	0.000114	0.000132	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—PDGFRA—refractive error	0.00011	0.000128	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—PML—refractive error	0.000108	0.000125	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—VANGL2—refractive error	0.000108	0.000125	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—PDGFRA—refractive error	0.000107	0.000125	CbGpPWpGaD
Ruxolitinib—JAK2—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.000107	0.000124	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR in disease—PTEN—refractive error	0.000107	0.000124	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 interactions—PTEN—refractive error	0.000107	0.000124	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—PDGFRA—refractive error	0.000107	0.000124	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—PDGFRA—refractive error	0.000107	0.000124	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR—PTEN—refractive error	0.000106	0.000123	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR in Cancer—PTEN—refractive error	0.000105	0.000122	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by PDGF—PTEN—refractive error	0.000105	0.000122	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—PML—refractive error	0.000105	0.000121	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—PDGFRA—refractive error	0.000104	0.000121	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—PDGFRA—refractive error	0.000104	0.00012	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—PTEN—refractive error	0.000103	0.000119	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—BMP2—refractive error	0.000102	0.000118	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—PML—refractive error	0.000102	0.000118	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—WNT10A—refractive error	0.0001	0.000116	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—PDGFRA—refractive error	9.97e-05	0.000116	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—PTEN—refractive error	9.92e-05	0.000115	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—PDGFRA—refractive error	9.81e-05	0.000114	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—COL9A1—refractive error	9.71e-05	0.000113	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—PTEN—refractive error	9.63e-05	0.000112	CbGpPWpGaD
Ruxolitinib—JAK2—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	9.49e-05	0.00011	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—RPS27—refractive error	9.43e-05	0.000109	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RNF111—refractive error	9.42e-05	0.000109	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CER1—refractive error	9.42e-05	0.000109	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TJP2—refractive error	9.42e-05	0.000109	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—COL9A1—refractive error	9.42e-05	0.000109	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—PTEN—refractive error	9.39e-05	0.000109	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—COL9A1—refractive error	9.14e-05	0.000106	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—BMP2—refractive error	8.75e-05	0.000102	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—BMP2—refractive error	8.6e-05	9.98e-05	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—PTEN—refractive error	8.49e-05	9.85e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—PDGFRA—refractive error	8.44e-05	9.8e-05	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—PTEN—refractive error	8.36e-05	9.7e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—PDGFRA—refractive error	8.11e-05	9.41e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—PML—refractive error	7.93e-05	9.21e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—PDGFRA—refractive error	7.8e-05	9.05e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—PDGFRA—refractive error	7.52e-05	8.73e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—PTEN—refractive error	7.44e-05	8.64e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—PTEN—refractive error	7.3e-05	8.47e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—COL9A1—refractive error	7.14e-05	8.29e-05	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—PTEN—refractive error	7.11e-05	8.25e-05	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—PTEN—refractive error	6.99e-05	8.11e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—BMP2—refractive error	6.65e-05	7.72e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—PTEN—refractive error	6.57e-05	7.63e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—BMP2—refractive error	6.46e-05	7.49e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—PDGFRA—refractive error	6.42e-05	7.45e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—PDGFRA—refractive error	6.35e-05	7.36e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—BMP2—refractive error	6.26e-05	7.27e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—PDGFRA—refractive error	6.23e-05	7.23e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—PDGFRA—refractive error	6.05e-05	7.02e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—PTEN—refractive error	5.97e-05	6.93e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—PTEN—refractive error	5.95e-05	6.9e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—EBP—refractive error	5.9e-05	6.84e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PDGFRA—refractive error	5.75e-05	6.68e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—PTEN—refractive error	5.66e-05	6.57e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—PTEN—refractive error	5.51e-05	6.4e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—PTEN—refractive error	5.49e-05	6.38e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—PTEN—refractive error	5.47e-05	6.35e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—PDGFRA—refractive error	5.46e-05	6.33e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—PDGFRA—refractive error	5.37e-05	6.23e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—PTEN—refractive error	5.34e-05	6.2e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—PTEN—refractive error	5.33e-05	6.18e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—PTEN—refractive error	5.12e-05	5.94e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—PTEN—refractive error	5.04e-05	5.85e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—BMP2—refractive error	4.89e-05	5.68e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—PDGFRA—refractive error	4.72e-05	5.48e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—DSE—refractive error	4.47e-05	5.19e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PDGFRA—refractive error	4.36e-05	5.06e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—PTEN—refractive error	4.33e-05	5.03e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—PTEN—refractive error	4.16e-05	4.83e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PDGFRA—refractive error	4.15e-05	4.82e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PDGFRA—refractive error	4.03e-05	4.68e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—PTEN—refractive error	4e-05	4.64e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PCCA—refractive error	3.98e-05	4.62e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PLA2G16—refractive error	3.98e-05	4.62e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PDGFRA—refractive error	3.91e-05	4.54e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—PTEN—refractive error	3.86e-05	4.48e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—PTEN—refractive error	3.3e-05	3.83e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—PTEN—refractive error	3.26e-05	3.78e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—PTEN—refractive error	3.2e-05	3.71e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—PTEN—refractive error	3.1e-05	3.6e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PDGFRA—refractive error	3.05e-05	3.54e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PTEN—refractive error	2.95e-05	3.43e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—PTEN—refractive error	2.8e-05	3.25e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—LUM—refractive error	2.76e-05	3.2e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—PTEN—refractive error	2.76e-05	3.2e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CACNA1D—refractive error	2.66e-05	3.08e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—PTEN—refractive error	2.43e-05	2.81e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP26A1—refractive error	2.35e-05	2.72e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PTEN—refractive error	2.24e-05	2.6e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PTEN—refractive error	2.13e-05	2.47e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PTEN—refractive error	2.07e-05	2.4e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PTEN—refractive error	2.01e-05	2.33e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PTEN—refractive error	1.57e-05	1.82e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTEN—refractive error	5.3e-06	6.15e-06	CbGpPWpGaD
